Neuromagnetic Amygdala Response to Pain-Related Fear as a Brain Signature of Fibromyalgia

Abstract

Introduction Fibromyalgia (FM) is a chronic pain condition characterized by impaired emotional regulation. This study explored the brain response to pain-related fear as a potential brain signature of FM. Methods We used a conditioned fear task and magnetoencephalography to record pain-related fear responses in patients with FM. Two blocks of 30 fear responses were collected to compute the response strength in the first block and the strength difference between the first and second blocks (fear habituation). These measurements were investigated for their clinical relevance and compared with measurements obtained from healthy controls and patients with chronic migraine (CM), a different chronic pain condition often comorbid with FM. Results Pain-related fear clearly activated the bilateral amygdala and anterior insula in patients with FM ( n = 52), patients with CM ( n = 50), and the controls ( n = 30); the response strength in the first block was consistent across groups. However, fear habituation in the right amygdala decreased in the FM group (vs. CM and control groups, both p ≤ 0.001, no difference between CM and control groups). At the 3-month follow-up, the patients with FM reporting < 30% improvement in pain severity ( n = 15) after pregabalin treatment exhibited lower fear habituation in the left amygdala at baseline (vs. ≥ 30% improvement, n = 22, p = 0.019). Receiver operating characteristic analysis confirmed that amygdala fear habituation is a suitable predictor of diagnosis and treatment outcomes of FM (area under the curve > 0.7). Conclusions Amygdala activation to pain-related fear is maladaptive and linked to treatment outcomes in patients with FM. Because the aberrant amygdala response was not observed in the CM group, this response is a potential brain signature of FM. Trial Registration ClinicalTrials.gov Identifier, NCT02747940.

Neural Correlates of Control Over Pain in Fibromyalgia Patients

“…Instead, the evaluation of our patient data revealed enhanced activity of structures within the limbic system that are typically associated with emotional responses and affective states (amygdala, parahippocampal gyrus) (Davis and Whalen, 2001;Gosselin, 2006;Phelps and LeDoux, 2005). Comparable activations during experimental pain have previously been demonstrated for low perceived levels of control as well as high levels of pain-related fear and pain catastrophizing (amygdala and hippocampus) (Gracely, 2004;Hsiao et al, 2020;Lu et al, 2010). In chronic pain disorders, painrelated activation of the amygdala has primarily been ascribed a painenhancing influence (Palazzo et al, 2008).…”

Optimization of Parkinson's disease therapy with plant extracts and nutrition’s evolving roles

“…The deficiency of Vitamin D has been reported to play a key role in the pathogenesis and progression of PD ( Chao et al, 2012 , Deluca et al, 2013 , Wrzosek et al, 2013 ). The efficacy of Vitamin D was revealed in the 6-OHDA-induced and MPP+-induced neurotoxicity by improving the motor functions in the PD rodents ( Hsiao et al, 2020 , Lima et al, 2018 ). It was observed that treatment of PD mice with vitamin D3 attenuated motor function deficits by upregulating the expression of tyrosine hydroxylase enzyme (a rate-determining enzyme in the synthesis of dopamine), dopamine transporter (DAT), and brain-derived neurotrophic factor (BDNF) in PD mice ( Bayo-olugbami et al, 2020 ).…”

Differential Brain Perfusion Changes Following Two Mind–Body Interventions for Fibromyalgia Patients: an Arterial Spin Labelling fMRI Study

“…They have provided evidence of altered functional connectivity (FC) of the default mode network (DMN) (Fallon et al, 2016 ) and cognitive control network in FMS patients compared to healthy controls (Kong et al, 2018 ), as well as changes in the aforementioned networks following transcranial direct current stimulation to the motor cortex (Cummiford et al, 2016 ), cognitive behavioural therapy (Jensen et al, 2012a , b , c ), hypnosis (Derbyshire et al, 2009 ) or mindfulness (Young et al, 2018 ). The amygdala seems to play a key role in encoding major targets of psychological therapies for chronic pain, such as depression (Giesecke et al, 2005 ) or anxiety and fear of pain (Hsiao et al, 2020 ). Studies using sustained-pain BOLD fMRI paradigms point towards FC increases of the somatosensory cortex with the insula during pain in FMS patients (Kim et al, 2015 ) which can be altered with cognitive therapy (Lazaridou et al, 2017 ); they also suggest that there is less FC within the pain inhibitory network during pressure pain, using the rostral anterior cingulate cortex (ACC) as seed (Jensen et al, 2012a , b , c ).…”